Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.

Kang Z, Min X, Weinreb J, Li Q, Feng Z, Wang L.

AJR Am J Roentgenol. 2019 Feb;212(2):357-365. doi: 10.2214/AJR.18.20103. Epub 2018 Dec 4.

PMID:
30512996
2.

Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.

Woo S, Suh CH, Kim SY, Cho JY, Kim SH, Moon MH.

AJR Am J Roentgenol. 2018 Nov;211(5):W226-W241. doi: 10.2214/AJR.18.19880. Epub 2018 Sep 21.

PMID:
30240296
3.

Diagnostic Performance of Biparametric MRI for Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.

Niu XK, Chen XH, Chen ZF, Chen L, Li J, Peng T.

AJR Am J Roentgenol. 2018 Aug;211(2):369-378. doi: 10.2214/AJR.17.18946. Epub 2018 Jun 12.

PMID:
29894216
4.

Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).

Gatti M, Faletti R, Calleris G, Giglio J, Berzovini C, Gentile F, Marra G, Misischi F, Molinaro L, Bergamasco L, Gontero P, Papotti M, Fonio P.

Abdom Radiol (NY). 2019 Feb 20. doi: 10.1007/s00261-019-01934-3. [Epub ahead of print]

PMID:
30788558
5.

Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.

Choi MH, Kim CK, Lee YJ, Jung SE.

AJR Am J Roentgenol. 2019 Feb 19:1-8. doi: 10.2214/AJR.18.20498. [Epub ahead of print]

PMID:
30779662
6.

Biparametric MRI of the prostate.

Scialpi M, D'Andrea A, Martorana E, Malaspina CM, Aisa MC, Napoletano M, Orlandi E, Rondoni V, Scialpi P, Pacchiarini D, Palladino D, Dragone M, Di Renzo G, Simeone A, Bianchi G, Brunese L.

Turk J Urol. 2017 Dec;43(4):401-409. doi: 10.5152/tud.2017.06978. Epub 2017 Dec 1. Review. Erratum in: Turk J Urol. 2018 Jan;44(1):91.

7.

Biparametric versus Multiparametric MRI with Non-endorectal Coil at 3T in the Detection and Localization of Prostate Cancer.

Scialpi M, Prosperi E, D'Andrea A, Martorana E, Malaspina C, Palumbo B, Orlandi A, Falcone G, Milizia M, Mearini L, Aisa MC, Scialpi P, DE Dominicis C, Bianchi G, Sidoni A.

Anticancer Res. 2017 Mar;37(3):1263-1271. Erratum in: Anticancer Res. 2017 Jul;37(7):3981.

PMID:
28314291
8.

Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.

Radtke JP, Boxler S, Kuru TH, Wolf MB, Alt CD, Popeneciu IV, Steinemann S, Huettenbrink C, Bergstraesser-Gasch C, Klein T, Kesch C, Roethke M, Becker N, Roth W, Schlemmer HP, Hohenfellner M, Hadaschik BA.

Prostate Cancer Prostatic Dis. 2015 Sep;18(3):288-96. doi: 10.1038/pcan.2015.29. Epub 2015 Jun 16.

PMID:
26078202
9.

Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.

Boesen L, Nørgaard N, Løgager V, Balslev I, Bisbjerg R, Thestrup KC, Winther MD, Jakobsen H, Thomsen HS.

JAMA Netw Open. 2018 Jun 1;1(2):e180219. doi: 10.1001/jamanetworkopen.2018.0219.

10.

Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.

Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, Taneja SS, Thoeny H, Villeirs G, Villers A.

Eur Urol. 2015 Dec;68(6):1045-53. doi: 10.1016/j.eururo.2015.01.013. Epub 2015 Feb 2. Review.

PMID:
25656808
11.

What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.

Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RCN, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TB, Rouvière O.

Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21. Review.

PMID:
28336078
12.

Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?

Junker D, Steinkohl F, Fritz V, Bektic J, Tokas T, Aigner F, Herrmann TRW, Rieger M, Nagele U.

World J Urol. 2018 Aug 4. doi: 10.1007/s00345-018-2428-y. [Epub ahead of print]

PMID:
30078170
13.

A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer.

Zhang L, Tang M, Chen S, Lei X, Zhang X, Huan Y.

Eur Radiol. 2017 Dec;27(12):5204-5214. doi: 10.1007/s00330-017-4843-7. Epub 2017 Jun 27. Review.

PMID:
28656462
14.

Short review of biparametric prostate MRI.

Steinkohl F, Pichler R, Junker D.

Memo. 2018;11(4):309-312. doi: 10.1007/s12254-018-0458-1. Epub 2018 Nov 12. Review.

15.

Multiparametric MRI in detection and staging of prostate cancer.

Boesen L.

Dan Med J. 2017 Feb;64(2). pii: B5327. Review.

PMID:
28157066
16.

Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.

Brown LC, Ahmed HU, Faria R, El-Shater Bosaily A, Gabe R, Kaplan RS, Parmar M, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham A, Oldroyd R, Parker C, Bott S, Burns-Cox N, Dudderidge T, Ghei M, Henderson A, Persad R, Rosario DJ, Shergill I, Winkler M, Soares M, Spackman E, Sculpher M, Emberton M.

Health Technol Assess. 2018 Jul;22(39):1-176. doi: 10.3310/hta22390.

17.

Magnetic resonance imaging in prostate cancer detection and management: a systematic review.

Monni F, Fontanella P, Grasso A, Wiklund P, Ou YC, Randazzo M, Rocco B, Montanari E, Bianchi G.

Minerva Urol Nefrol. 2017 Dec;69(6):567-578. doi: 10.23736/S0393-2249.17.02819-3. Epub 2017 May 8. Review.

18.

Is contrast enhancement needed for diagnostic prostate MRI?

Scialpi M, Rondoni V, Aisa MC, Martorana E, D'Andrea A, Malaspina CM, Orlandi A, Galassi G, Orlandi E, Scialpi P, Dragone M, Palladino D, Simeone A, Amenta M, Bianchi G.

Transl Androl Urol. 2017 Jun;6(3):499-509. doi: 10.21037/tau.2017.05.31. Review.

19.

Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.

Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, Beer AJ, Wester HJ, Gschwend J, Schwaiger M, Maurer T.

Eur Urol. 2016 Nov;70(5):829-836. doi: 10.1016/j.eururo.2015.12.053. Epub 2016 Jan 18.

PMID:
26795686
20.

Transvaginal ultrasound vs magnetic resonance imaging for diagnosing deep infiltrating endometriosis: systematic review and meta-analysis.

Guerriero S, Saba L, Pascual MA, Ajossa S, Rodriguez I, Mais V, Alcazar JL.

Ultrasound Obstet Gynecol. 2018 May;51(5):586-595. doi: 10.1002/uog.18961. Review.

Supplemental Content

Support Center